CORTEXA
← Browse
openalexFrontiers in Oncology2026-07-23Cited by 0

Tumor progression is effectively suppressed by miR-195 through direct targeting of YAP1

Wang Xiao-wei, Jin‐Chao Song, Ming-Ming Tang, Yi-Yu He, Zhigang Cai

Background Yes-associated protein 1 (YAP1) dysregulation is frequently observed in various human cancers. This study aimed to identify microRNAs (miRNAs) capable of suppressing YAP1 expression and to elucidate their functional roles in tumor progression. Methods We screened five candidate miRNAs using a luciferase reporter assay containing the YAP1 3’ untranslated region (3’ UTR). Functional validation was performed using gain- and loss-of-function experiments in HCT116 and A549 cell lines. The in vivo effects of miR-195 were evaluated using a xenograft model. Results Among the tested miRNAs, miR-195 demonstrated the most potent suppression of YAP1 3’ UTR activity. This interaction was direct and specific, as a mutation in the YAP1 3’ UTR seed sequence abolished miR-195-mediated repression. Consequently, miR-195 overexpression significantly reduced endogenous YAP1 protein levels and suppressed the expression of its downstream target, CTGF. Functionally, miR-195 overexpression inhibited cell viability and reduced colony formation by approximately 40% in HCT116 cells, while miR-195 knockdown promoted proliferation. Rescue experiments confirmed that the anti-proliferative effects of miR-195 were dependent on YAP1 suppression. In vivo , stable overexpression of miR-195 significantly attenuated tumor growth in xenograft models. Furthermore, analysis of clinical data revealed that downregulation of miR-195 is prevalent in multiple tumor types and correlates with poor patient survival. Conclusion Our findings establish miR-195 as a critical tumor suppressor that directly targets YAP1, highlighting its potential as a therapeutic target in cancer treatment.

View free PDFSource page

Related papers

openalexFrontiers in Oncology2026-07-23

Tumor-derived miR-126 promotes tumor progression through immune modulation beyond the local tumor environment

Takashi Akazawa, Yu Mizote, Tomoya Ekawa, Satomi Yoshida, Yachiyo Kumamoto, Yoichiro Harada, et al.

Epidermal growth factor-like domain 7 (EGFL7) was discovered as an extracellular matrix protein with an EGF-like domain and angiogenic and vasculogenic functions. It has also been shown to play a role in immunological evasion of tumor cells through attenuation of extravasation of…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells

R K Watanabe, Mami Chosei, Haruna Arai, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika

Introduction Neuroendocrine prostate cancer (NEPC) is an aggressive treatment-associated lineage state emerging with potent androgen receptor (AR) pathway inhibition. Although treatment-emergent NEPC is increasingly recognized, the transcriptional consequences of sustained AR sup…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Down-regulation of THBS2 inhibits the malignant progression of Burkitt lymphoma by blocking the PI3K/AKT/c-MYC pathway

Yan Xu, Shengquan Liu, Shaoxiong Wang, Y Huang

Background Thrombospondin 2 (THBS2) is overexpressed in various solid tumors and is a prognostic gene of Burkitt lymphoma (BL), but its role and molecular mechanism in BL still need to be explored. Methods Western blot (WB) detected the protein expression of THBS2 in BL cells. si…

View free PDFSource page
openalexFrontiers in Oncology2026-07-23

Comparative efficacy and outcomes of different treatments for pathologically high-risk superficial esophageal cancer: a systematic review and network meta-analysis

He He, Hanlu Zhang, Haowen Lv, Ningying Ding, Wenping Wang

Background Endoscopic resection (ER) is increasingly used for superficial esophageal cancer (SEC), but pathological examination may reveal features associated with lymph-node metastasis or recurrence. The optimal management of patients with pathologically high-risk SEC remains un…

View free PDFSource page
openalexFrontiers in Oncology2026-07-23

Editorial: Liquid biopsy in non-small cell lung cancer for diagnosis, treatment selection and monitoring

A. Strati, Benoît Roch, Ammar Sukari

Lung cancer is the third most common malignancy in the United States and remains the leading cause of cancer-related mortality worldwide. Despite ongoing advances in diagnosis and therapy, survival rates for patients with lung cancer remain unsatisfactory (1). In recent years, in…

View free PDFSource page
openalexFrontiers in Oncology2026-07-24

Adenomatoid tumor of the testis in a patient with history of cryptorchidism, male breast cancer, and thymic B2 thymoma: a case report and literature review

Yunpeng Cao, Xi Zhang, Feifan Song, Lu Liu, Xiongjie Cui, Shen Li, et al.

Background Adenomatoid tumor is a rare benign neoplasm of mesothelial origin, most commonly arising in the epididymis, vas deferens, and tunica vaginalis; primary occurrence in the testis is extremely rare. Cryptorchidism is recognized as a risk factor for testicular germ cell tu…

View free PDFSource page